Literature DB >> 6619541

The influence of methotrexate and thymidine on the human natural killer cell function in vitro.

D S Matheson, B Green, D I Hoar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6619541

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  7 in total

Review 1.  Molecular mechanism of methotrexate action in inflammation.

Authors:  B N Cronstein
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

2.  Paradoxical enhancement of interleukin-2-mediated cytotoxicity against K562 cells by addition of a low dose of methotrexate.

Authors:  T Nakarai; Y Ueno; Y Ueno; S Koizumi
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

3.  Methotrexate for steroid-resistant systemic lupus erythematosus.

Authors:  M Hashimoto; S Nonaka; E Furuta; T Wada; Y Suenaga; M Yasuda; M Shingu; M Nobunaga
Journal:  Clin Rheumatol       Date:  1994-06       Impact factor: 2.980

4.  Improved outcome of children transplanted for high-risk leukemia by using a new strategy of cyclosporine-based GVHD prophylaxis.

Authors:  N Bleyzac; D Cuzzubbo; C Rénard; N Garnier; V Dubois; C Domenech; M-P Goutagny; A Plesa; N Grardel; S Goutelle; A Janoly-Duménil; Y Bertrand
Journal:  Bone Marrow Transplant       Date:  2016-01-25       Impact factor: 5.483

5.  Cell-type specific response of peripheral blood lymphocytes to methotrexate in the treatment of rheumatoid arthritis.

Authors:  T C Wascher; J Hermann; H P Brezinschek; R Brezinschek; M Wilders-Truschnig; F Rainer; G J Krejs
Journal:  Clin Investig       Date:  1994-07

6.  Phase I/II trial of lenalidomide, methotrexate, leucovorin, cytarabine, and rituximab (LeMLAR) in relapsed or refractory diffuse large B cell lymphoma.

Authors:  Ulrich Dührsen; Mareike Tometten; Frank Kroschinsky; Arnold Ganser; Stefan Ibach; Stefanie Bertram; Andreas Hüttmann
Journal:  Blood Cancer J       Date:  2021-05-17       Impact factor: 11.037

7.  Small-Molecule Immunosuppressive Drugs and Therapeutic Immunoglobulins Differentially Inhibit NK Cell Effector Functions in vitro.

Authors:  Amandine Pradier; Maria Papaserafeim; Ning Li; Anke Rietveld; Charlotte Kaestel; Lyssia Gruaz; Cédric Vonarburg; Rolf Spirig; Gisella L Puga Yung; Jörg D Seebach
Journal:  Front Immunol       Date:  2019-03-27       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.